01.08.2026VitrofluidiX has been selected as one of 12 teams for the SPRIND Orbital BioWorks Challenge! Over the next four months,…- 09.07.2026VitrofluidiX is proud to support Organ-on-Chip research in collaboration with Fraunhofer IZI, contributing our VitroFlow perfusion platform to research in…
29.05.2026Text / Beitrag The MPS World Summit is one of the most important international conferences for microphysiological systems (MPS) and…- 26.05.2026Thrilled to officially partner with MicrofluidicChipShop🚀 By combining microfluidic MicrofluidicChipShop’s broad microfluidics portfolio with our VitroFlow platform, we can offer…
16.04.2026After 6 years of development, VitroFlow.Bio is ready for early customer access 🚀🧪 We built this platform because we kept…
23.03.2026The FDA recently released new draft guidance on the use of New Approach Methodologies (NAMs) in drug development, marking another…- 12.03.2026🔬 We were proud to be a sponsor of the 2nd Bonn Organoid Symposium 2026. On March 12, the Rheinische…
28.02.2026Great to be back at Session 3 of the Creative Destruction Lab (CDL) Health Stream in Heidelberg. 🚀 The session…
23.02.2026📢 We’re proud to see VitrofluidiX mentioned in Preqin First Close Weekly (January 23, 2026). In this edition, Preqin highlights…- 16.02.2026We’ve moved! 🚀📍VitrofluidiX has officially relocated to the RTZ Köln. Our new location provides a larger lab, an expanded workshop,…
